1 Tomita, M, Bellamy, W, Takase, M, et al. (1991) Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J Dairy Sci 74, 4137–4142.
2 Harmsen, MC, Swart, PJ, de Béthune, MP, et al. (1995) Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis 172, 380–388.
3 Zimecki, M, Właszczyk, A, Cheneau, P, et al. (1998) Immunoregulatory effects of a nutritional preparation containing bovine lactoferrin taken orally by healthy individuals. Arch Immunol Ther Exp 46, 231–240.
4 Shoji, H, Oguchi, S, Shinohara, K, et al. (2007) Effects of iron-unsaturated human lactoferrin on hydrogen peroxide-induced oxidative damage in intestinal epithelial cells. Pediatr Res 61, 89–92.
5 Sekine, K, Ushida, Y, Kuhara, T, et al. (1997) Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Lett 121, 211–216.
6 Suzuki, N, Kigawa, H, Ono, T, et al. (2007) . In The Lactoferrin 2007, pp. 68–72 [Thuda, H, Shimazaki, K and Tanaka, K, editors]. Tokyo: Nihon Igakukan.
7 Takeuchi, T, Shimizu, H, Ando, K, et al. (2004) Bovine lactoferrin reduces plasma triacylglycerol and NEFA accompanied by decreased hepatic cholesterol and triacylglycerol contents in rodents. Br J Nutr 91, 533–538.
8 Tamano, S, Sekine, K, Takase, M, et al. (2008) Lack of chronic oral toxicity of chemopreventive bovine lactoferrin in F344/DuCrj rats. Asian Pac J Cancer Prev 9, 313–316.
9 Tokunaga, K, Matsuzawa, Y, Ishikawa, K, et al. (1983) A novel technique for the determination of body fat by computed tomography. Int J Obes 7, 437–445.
10 Richmond, W (1973) Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19, 1350–1356.
11 Sugiuchi, H, Uji, Y, Okabe, H, et al. (1995) Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated α-cyclodextrin. Clin Chem 41, 717–723.
12 Kanno, T, Sakurabayashi, I, Saito, Y, et al. (1997) Evaluation of a new assay for determination of LDL-cholesterol. Jpn J Med Pharm Sci 37, 635–644.
13 Eggstein, M & Kreutz, FH (1966) A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method (article in German). Klin Wochenschr 44, 262–267.
14 Frings, CS & Dunn, RT (1970) A colorimetric method for determination of total serum lipids based on the sulfo-phospho-vanillin reaction. Am J Clin Pathol 53, 89–91.
15 Okabe, H, Uji, Y, Nagashima, K, et al. (1980) Enzymic determination of free fatty acids in serum. Clin Chem 26, 1540–1543.
16 Gornall, AG, Bardawill, CJ & David, MM (1949) Determination of serum proteins by means of the biuret reaction. J Biol Chem 177, 751–766.
17 Doumas, BT, Watson, WA & Biggs, HG (1971) Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 31, 87–96.
19 Otsuji, S, Mizuno, K, Ito, S, et al. (1988) A new enzymatic approach for estimating total and direct bilirubin. Clin Biochem 21, 33–38.
20 Tanganelli, E, Prencipe, L, Bassi, D, et al. (1982) Enzymic assay of creatinine in serum and urine with creatinine iminohydrolase and glutamate dehydrogenase. Clin Chem 28, 1461–1464.
21 Tabacco, A, Meiattini, F, Moda, E, et al. (1979) Simplified enzymic/colorimetric serum urea nitrogen determination. Clin Chem 25, 336–337.
22 Gochman, N & Schmitz, JM (1971) Automated determination of uric acid, with use of a uricase-peroxidase system. Clin Chem 17, 1154–1159.
23 Férard, G, Goester, C, Klumpp, T, et al. (1980) Evaluation of immunonephelometry of C-reactive protein in serum. Clin Chem 26, 782–783.
24 Sugiura, M & Hirano, K (1977) A new colorimetric method for determination of serum glucose. Clin Chim Acta 75, 387–391.
25 John, WG (1996) Hemoglobin A1c measurement: new precise immunoassay method involving latex particle agglutination. Clin Chem 42, 1874–1875.
26 Yoshioka, M, Taniguchi, H, Kawaguchi, A, et al. (1979) Evaluation of a commercial enzyme immunoassay for insulin in human serum, and its clinical application. Clin Chem 25, 35–38.
28 Shimazaki, K & Yoshimoto, Y (1988) Distribution of bovine lactoferrin in curd and whey (article in Japanese). Jpn J Dairy Food Sci 37, A106–A108.
29 Moreno-Navarrete, JM, Ortega, FJ, Bassols, J, et al. (2008) Association of circulating lactoferrin concentration and 2 nonsynonymous LTF gene polymorphisms with dyslipidemia in men depends on glucose-tolerance status. Clin Chem 54, 301–309.
30 Moreno-Navarrete, JM, Ortega, FJ, Bassols, J, et al. (2009) Decreased circulating lactoferrin in insulin resistance and altered glucose tolerance as a possible marker of neutrophil dysfunction in type 2 diabetes. J Clin Endocrinol Metab 94, 4036–4044.
31 Cani, PD, Amar, J, Iglesias, MA, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772.
32 Wakabayashi, H, Takase, M & Tomita, M (2003) Lactoferricin derived from milk protein lactoferrin. Curr Pharm Des 9, 1277–1287.
33 Takeuchi, T, Kitagawa, H, Harada, E, et al. (2004) Evidence of lactoferrin transportation into blood circulation from intestine via lymphatic pathway in adult rats. Exp Physiol 89, 263–270.
34 Fischer, R, Debbabi, H, Blais, A, et al. (2007) Uptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues. Int Immunopharmacol 7, 1387–1393.
35 Yagi, M, Suzuki, N, Takayama, T, et al. (2008) Lactoferrin suppresses the adipogenic differentiation of MC3T3-G2/PA6 cells. J Oral Sci 50, 419–425.
36 Moreno-Navarrete, JM, Ortega, FJ, Ricart, W, et al. (2009) Lactoferrin increases (172Thr) AMPK phosphorylation and insulin-induced (p473Ser)AKT while impairing adipocyte differentiation. Int J Obes (Lond) 33, 991–1000.
37 Crawford, SE & Borensztajn, J (1999) Plasma clearance and liver uptake of chylomicron remnants generated by hepatic lipase lipolysis: evidence for a lactoferrin-sensitive and apolipoprotein E-independent pathway. J Lipid Res 40, 797–805.
38 Hofmann, SM, Zhou, L, Perez-Tilve, D, et al. (2007) Adipocyte LDL receptor-related protein-1 expression modulates postprandial lipid transport and glucose homeostasis in mice. J Clin Invest 117, 3271–3282.